Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

3.860 -0.040 (-1.03%)
Streaming Delayed Price Updated: 3:26 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
From GoodRx
Via Business Wire
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
From GoodRx
Via Business Wire
GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy
From GoodRx
Via Business Wire
GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing
From GoodRx
Via Business Wire
GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month
From GoodRx
Via Business Wire
GoodRx Reports Second Quarter 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions
From GoodRx
Via Business Wire
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX
From Kahn Swick & Foti, LLC
Via Business Wire
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
From GoodRx
Via Business Wire
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing
From GoodRx
Via Business Wire
GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity
From GoodRx
Via Business Wire
GoodRx to Launch Direct Contracting for Independent Community Pharmacies
From GoodRx
Via Business Wire
GoodRx Reports First Quarter 2025 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Introduces New E-commerce Experience for Retail Pharmacies
From GoodRx
Via Business Wire
GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement
From GoodRx
Via Business Wire
GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending
From GoodRx
Via Business Wire
GoodRx Reports Fourth Quarter and Full Year 2024 Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats
From GoodRx
Via Business Wire
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
From GoodRx
Via Business Wire
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
From GoodRx Holdings, Inc.
Via Business Wire
Scott Wagner Joins GoodRx Board of Directors
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
From GoodRx
Via Business Wire
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
From GoodRx
Via Business Wire
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
From GoodRx
Via Business Wire
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
From GoodRx
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.